Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "BioPharmaceuticals"

180 News Found

SK Biopharmaceuticals joins Pharmaceutical Supply Chain Initiative
Supply Chain | February 25, 2022

SK Biopharmaceuticals joins Pharmaceutical Supply Chain Initiative

PSCI, a global non-profit organization, works with its members to ensure a positive environment that can improve global healthcare supply chains


We achieved  40% revenue growth in 2021 : Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals
Interviews | January 11, 2022

We achieved 40% revenue growth in 2021 : Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals

The biopharmaceutical market has been on a growth curve. India is number three in the Asia Pacific market. Gaurav Kaushik, MD & Director & CEO, Meteoric Biopharmaceuticals shares a perspective on the industry


We achieved 40% revenue growth in 2021: Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals
interviews | January 10, 2022

We achieved 40% revenue growth in 2021: Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals

The biopharmaceutical market has been on a growth curve. India is number three in the Asia Pacific market. Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals shares a perspective on the industry


Aurobindo arm CuraTeQ receives Health Canada approval for bevacizumab biosimilar Bevqolva
Drug Approval | May 04, 2026

Aurobindo arm CuraTeQ receives Health Canada approval for bevacizumab biosimilar Bevqolva

Notice of Compliance from Health Canada enables marketing authorisation for cancer biosimilar in Canadian market


Syngene appoints Maninder Kapoor Puri as CHRO and Abhijit Zutshi as CCO
People | May 01, 2026

Syngene appoints Maninder Kapoor Puri as CHRO and Abhijit Zutshi as CCO

Both join the leading CRDMO’s executive committee to drive global people strategy and commercial expansion


JP Nadda highlights India’s push for APIs, biologics and translational research
Policy | May 01, 2026

JP Nadda highlights India’s push for APIs, biologics and translational research

On his visit to NIPER Mohali, union health minister vreviews biopharma research initiatives and calls for stronger industry collaboration and commercialization focus


FDA okays AstraZeneca’s triple therapy Breztri for asthma
Medical Device | April 29, 2026

FDA okays AstraZeneca’s triple therapy Breztri for asthma

The aim is to simplify and strengthen long-term control of airway disease through triple therapy in one device


Piramal Pharma Solutions appoints Gregory Judge as Director to strengthen European business
People | April 28, 2026

Piramal Pharma Solutions appoints Gregory Judge as Director to strengthen European business

In his new role, Gregory will drive partnerships for the company’s large-scale molecule biologics business across Europe


AstraZeneca wins US nod for at-home lupus treatment in major shift for SLE care
News | April 28, 2026

AstraZeneca wins US nod for at-home lupus treatment in major shift for SLE care

The approval was driven by data from the Phase III TULIP-SC trial


Gennova CEO Dr Sanjay Singh sees strong innovation momentum for India’s biopharma sector
Biopharma | April 14, 2026

Gennova CEO Dr Sanjay Singh sees strong innovation momentum for India’s biopharma sector

Veteran biopharma leader stressed that generic medicines must be viewed separately from biologics